Table 1.

Subject baseline demographics

QBX1‐1 study
n		Sex	Age,† years	Weight,† kg	BMI,† kg/m2
22		M	21.9 ± 2.4 (20–30)	60.6 ± 6.9 (50.5–81.8)	20.7 ± 1.26 (18.6–24.3)

QBX1‐2 study
Part	Group	n	Sex, n	Age, years	Weight, kg	BMI, kg/m2
1	Placebo	2	M, 2; F, 0	24.5	64.2	23.1
	3%	6	M, 6; F, 0	21.0 ± 1.3 (20–23)	64.4 ± 7.4 (57.3–77.3)	21.7 ± 1.5 (19.4–23.3)
2	Placebo	4	M, 3; F, 1	30.8 ± 14.0 (21–51)	67.1 ± 10.7 (55.5–78.1)	24.6 ± 3.3 (21.1–28.8)
	1%	6	M, 4; F, 2	33.0 ± 13.1 (22–55)	55.7 ± 6.6 (50.9–68.7)	21.1 ± 2.0 (18.5–23.4)
	3%	6	M, 4; F, 2	26.8 ± 9.6 (20–45)	60.9 ± 7.1 (51.9–71.6)	22.0 ± 1.8 (18.9–24.0)
3	Placebo	4	M, 3; F, 1	24.8 ± 5.6 (21–33)	68.7 ± 7.4 (61.6–79.0)	24.2 ± 6.1 (19.9–33.1)
	1%	8	M, 8; F, 0	26.5 ± 5.4 (21–35)	64.4 ± 8.6 (54.8–79.0)	22.4 ± 2.0 (19.6–25.4)
	3%	8	M, 7; F, 1	30.0 ± 8.2 (21–43)	63.0 ± 9.7 (53.6–78.5)	22.7 ± 3.2 (19.1–27.2)

^†Mean ± standard deviation (range). BMI, body mass index; F, female; M, male; n, number of patients.